Queensland Subordinate Legislation as Made
[Index]
[Table]
[Search]
[Search this Act]
[Notes]
[Noteup]
[Download]
[Help]
PUBLIC HEALTH (MEDICINAL CANNABIS) REGULATION 2017
- Made under the Public Health (Medicinal Cannabis) Act 2016
- As at 24 February 2017
- Reg 15 of 2017
TABLE OF PROVISIONS
PART 1 - INTRODUCTION
Division 1 - Preliminary
1. Short title
2. Commencement
3. Definitions
Division 2 - General provisions
4. Compliance with code, guideline, protocol or standard
5. Language of documents
PART 2 - MANUFACTURING APPROVALS AND WHOLESALING APPROVALS
Division 1 - Preliminary
6. Definitions for part
7. Consistency with Commonwealth law
8. Evidentiary aids
Division 2 - Application for approvals
Subdivision 1 - Preliminary
9. Suitability of person to hold approval
10. Approved form
Subdivision 2 - Particular provisions for application for manufacturing approval
11. Purpose of subdivision
12. Who may apply for manufacturing approval
13. Criteria for grant or renewal of manufacturing approval
Subdivision 3 - Particular provisions for application for wholesaling approval
14. Purpose of subdivision
15. Who may apply for wholesaling approval
16. Criteria for grant or renewal of wholesaling approval
Subdivision 4 - Process for deciding applications
17. Decision on application for approval
18. Chief executive may require information or documents
19. Chief executive may extend period for decision for complex application
20. Failure to decide application
Division 3 - Grant of approvals
Subdivision 1 - Conditions, term and transfer
21. Standard conditions for manufacturing approvals
22. Standard conditions for wholesaling approvals
23. Additional or varied conditions for approvals
24. Term of approvals
25. Transfer of approvals prohibited
Subdivision 2 - Form of approvals
26. Form of manufacturing approval
27. Form of wholesaling approval
Division 4 - Amendment, replacement and renewal of approvals
Subdivision 1 - Preliminary
28. Making applications
29. Process for deciding application
Subdivision 2 - Amendment
30. Application by holder to amend approval
31. Minor amendment of approval by chief executive
Subdivision 3 - Replacement
32. Application for replacement of approval
33. Criteria for deciding replacement application
Subdivision 4 - Renewal
34. Application for renewal of approval
35. Approval taken to be in force while renewal application considered
Division 5 - Return and surrender of approvals
36. Return of instrument of approval
Division 6 - Authority under approvals
37. Manufacturing approval does not grant authority to manufacture
38. Authority under wholesaling approval
Division 7 - Particular provisions for wholesaling approvals
39. Wholesaling code
40. Wholesaler to give invoice when wholesaling medicinal cannabis
41. Automatic grant, renewal, variation, suspension, cancellation and surrender of wholesaling approval
Division 8 - Administrative action
42. Definition for division
43. Grounds for action to be taken
44. Show cause notice
45. Representations about show cause notices
46. Ending show cause process without further action
47. Decision to take administrative action
48. Immediate administrative action
Division 9 - Offences
49. Offence for false or misleading statements or documents
50. Offence for failure to comply with approval conditions
PART 3 - OTHER DEALINGS WITH MEDICINAL CANNABIS
Division 1 - Medicinal cannabis approvals, dispensing approvals and clinical trial approvals
51. Standard conditions for medicinal cannabis approvals—Act, s 34(1)
52. Standard conditions for dispensing approvals—Act, s 34(1)
53. Standard conditions for clinical trial approvals—Act, s 34(1)
Division 2 - Patient-class prescribers
54. Prescribed specialist medical practitioners—Act, s 52(1)(a)
55. Prescribed classes of patients—Act, s 52(2)(a)
56. Prescribed medicinal cannabis—Act, s 52(2)(b)
57. Conditions for patient-class prescribers—Act, s 52(1)(b)
Division 3 - Restricted access patients
58. Prescribed persons—Act, s 61(7), definition prescribed person
Division 4 - Authorised ways and eligible persons
Subdivision 1 - Preliminary
59. Definitions for division
60. Eligible persons and authorised ways—Act, s 68
Subdivision 2 - Hospital staff
61. Dosage conditions do not apply to authorised hospital staff members
62. Authority ends when relevant patient leaves hospital
63. Use of patient-supplied medicinal cannabis
64. Hospital doctors
65. Enrolled nurses
66. Registered nurses
67. Pharmacists
68. Pharmacy technicians
Subdivision 3 - State analysts and trainee State analysts
69. Manufacture of medicinal cannabis
Division 5 - Offences
70. Misuse of written instruction for medicinal cannabis
71. Unsafe disposal or use of medicinal cannabis
Division 6 - Medicinal cannabis management plans
72. Additional matters to be dealt with in medicinal cannabis management plans—Act s 70(4)
PART 4 - LAWFUL DIRECTIONS
Division 1 - Lawful directions generally
73. Preventing fraudulent lawful directions
Division 2 - Prescriptions
Subdivision 1 - Prescriptions generally
74. Prescriptions for medicinal cannabis
75. Form of prescriptions
76. Content of prescriptions
Subdivision 2 - Paper prescriptions
77. Paper prescriptions generated by computer
78. Electronic communication of paper prescriptions
Subdivision 3 - Electronic prescriptions
79. Electronic prescriptions
PART 5 - DISPENSING MEDICINAL CANNABIS
Division 1 - Packaging and labelling
80. Packaging
81. Labelling generally
82. Labelling by pharmacist
83. Labelling by single-patient prescribers and patient-class prescribers
84. Warnings to be printed on labels
85. Chief executive may approve alternative packaging or labelling
86. Restriction on using contaminated packages
87. Restriction on selling in second-hand packages
Division 2 - Dispensing
88. When medicinal cannabis must not be dispensed
89. Dealing with prescriptions
90. Issuing, selling or supplying medicinal cannabis after expiry date
Division 3 - Advertising medicinal cannabis
91. Advertising medicinal cannabis
PART 6 - RECORD-KEEPING
Division 1 - Record-keeping generally
92. Records may be made and kept electronically
93. Recording information on paper
94. Keeping information
95. Record to be made on day of transaction
96. Stocktake
97. Discrepancy to be immediately reported to chief executive
98. Records not to be changed but may be corrected
99. False, misleading or incomplete entries
Division 2 - Record-keeping by particular doctors
100. Particular doctors to record transactions involving medicinal cannabis
Division 3 - Record-keeping by pharmacists
101. Definition for division
102. Pharmacists to record transactions involving medicinal cannabis in controlled drugs record
103. Entries to be made in controlled drugs record
104. Pharmacist to keep documents
Division 4 - Record-keeping by wholesalers
105. Records of transactions to be kept by wholesalers
Division 5 - Record-keeping by hospitals and nursing homes
Subdivision 1 - Preliminary
106. Definitions for division
Subdivision 2 - Hospitals and nursing homes with multiple storage points
107. Application of subdivision
108. Main issue book
109. Details to be recorded in main issue book
110. Ward book
111. Details to be recorded in ward book when medicinal cannabis obtained into unit
112. Details to be recorded in ward book when medicinal cannabis administered in unit
113. Transfer vouchers may be used for medicinal cannabis in certain cases
114. Main issue book and ward book as 1 book
Subdivision 3 - Hospitals and nursing homes with 1 storage point
115. Application of subdivision
116. Single storage book
117. Details to be recorded in single storage book when medicinal cannabis deposited
118. Details to be recorded in single storage book when medicinal cannabis administered
Subdivision 4 - Other provisions about record-keeping by hospitals and nursing homes
119. Responsibility for checking accuracy of records at hospitals and nursing homes
PART 7 - TRANSPORTATION AND DELIVERY OF MEDICINAL CANNABIS
120. Definitions for part
121. Sending and delivering medicinal cannabis
122. Delivery of medicinal cannabis
123. Sending medicinal cannabis by carrier
PART 8 - STORAGE OF MEDICINAL CANNABIS
124. Relevant person must comply with standard
PART 9 - NOTIFICATION AND REPORTING
125. Definition for part
126. Single-patient prescribers
127. Patient-class prescribers
PART 10 - TRANSITIONAL PROVISIONS
128. Definitions for part
129. Existing licence to manufacture medicinal cannabis
130. Existing application for controlled drug manufacturer licence
131. Existing licence to wholesale medicinal cannabis
132. Existing application for controlled drug wholesaler licence
SCHEDULE 1
SCHEDULE 2
AustLII: Copyright Policy
| Disclaimers
| Privacy Policy
| Feedback